Cargando…
COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Editora Ltda.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603960/ http://dx.doi.org/10.1016/j.htct.2020.10.888 |
| _version_ | 1783604031693783040 |
|---|---|
| author | Dourado, M.L.B.F. Eira, V.B.A.S. Matias, G. Baiocchi, O.C.C.G. |
| author_facet | Dourado, M.L.B.F. Eira, V.B.A.S. Matias, G. Baiocchi, O.C.C.G. |
| author_sort | Dourado, M.L.B.F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7603960 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Editora Ltda. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76039602020-11-02 COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? Dourado, M.L.B.F. Eira, V.B.A.S. Matias, G. Baiocchi, O.C.C.G. Hematol Transfus Cell Ther 886 Published by Elsevier Editora Ltda. 2020-11 2020-10-31 /pmc/articles/PMC7603960/ http://dx.doi.org/10.1016/j.htct.2020.10.888 Text en Copyright © 2020 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | 886 Dourado, M.L.B.F. Eira, V.B.A.S. Matias, G. Baiocchi, O.C.C.G. COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title | COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title_full | COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title_fullStr | COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title_full_unstemmed | COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title_short | COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY? |
| title_sort | covid-19 in a patient with chronic lymphocytic leukemia in use of ibrutinib: not that risky? |
| topic | 886 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603960/ http://dx.doi.org/10.1016/j.htct.2020.10.888 |
| work_keys_str_mv | AT douradomlbf covid19inapatientwithchroniclymphocyticleukemiainuseofibrutinibnotthatrisky AT eiravbas covid19inapatientwithchroniclymphocyticleukemiainuseofibrutinibnotthatrisky AT matiasg covid19inapatientwithchroniclymphocyticleukemiainuseofibrutinibnotthatrisky AT baiocchioccg covid19inapatientwithchroniclymphocyticleukemiainuseofibrutinibnotthatrisky |